Regeneron to Add 2 New Bioreactors in NY Plant Expansion

- Last updated on GMT

Related tags: Monoclonal antibodies, Regeneron

Regeneron to Add 2 New Bioreactors in NY Plant Expansion
Regeneron will add two new 10,000-litre bioreactors at its East Greenbush facility as part of an $80m expansion.

The company is investing a total of $80m (€60m) on an expansion at the facility in New York, US, “to accommodate growth in [its] pipeline and commercial demand for [its] products,”​ Regeneron spokesperson Daniel Van Plew told our sister publication,

On top of the four 10,000-litre bioreactors currently at the site, an extra two will be added in a new 65,000 sq ft commercial-scale manufacturing site.

Though Van Plew said the growth could not be attributed “to any one product or to any particular regulatory approval,” ​the facility makes the firms lead product Eylea, a treatment for wet age-related macular degeneration.

According to Regeneron’s Q2 2013 results​, net sales of Eylea stood at $329.8m – up from $194m for the same period last year – comprising 72% of Regeneron’s total revenue for the quarter.

And Regeneron recently announced plans to boost monoclonal antibody production in Ireland with a deal that could see it buy a 400,000 sq ft facility in Limerick from computer manufacturer Dell. Read the full story here​.

Related news

Show more

Related products

show more

Manufacturing of hiPSC-Derived Cardiomyocytes

Manufacturing of hiPSC-Derived Cardiomyocytes

Eppendorf for Bioprocess – Solutions that grow with you | 29-Oct-2020 | Application Note

Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent...

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Related suppliers

Follow us


View more